A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 321 participants.
Also called NCT02741245
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 321 participants
- Sponsor
- Registry
-
NCT02741245
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02741245. Randomized; double masking; primary purpose treatment. Start 2016-06-09 (actual); primary completion 2017-01-18 (actual). Results posted on 2018-03-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Ezetimibe 10 mg
- Intervention (Drug)
- Rosuvastatin 2.5 mg
- Intervention (Drug)
- Placebo for Ezetimibe
- Intervention (Drug)
- Placebo for Rosuvastatin
- Lead sponsor
- Organon and Co
Record details
- Record id
cardio:ct-nct02741245- Content hash
28c54a4dad8a658679205f748da5e18260ccbec616e27d38db4bc32532efccc2